⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GERN News
Geron Corp
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
GERN
Geron Corporation Announces Strategic Restructuring Plan to Position the Company for Long-Term Value Creation
globenewswire.com
GERN
Geron Corporation Presents New Data at ASH 2025 Highlighting the Relationship Between Treatment-Emergent Cytopenias and Clinical Benefit of RYTELO® (Imetelstat) in Lower-Risk MDS
globenewswire.com
GERN
Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points
prnewswire.com
GTBP
GERN
KURA
SLS
TCRX
Geron Corporation Reports Third Quarter 2025 Financial Results and Recent Business Highlights
businesswire.com
GERN
Geron Corporation to Present at Upcoming Investor Conferences
businesswire.com
GERN
Geron Corporation Announces Five Presentations Selected for ASH 2025 Highlighting Clinical Activity of RYTELO® (imetelstat) in Myeloid Hematologic Malignancies
businesswire.com
GERN
Geron Plans to Announce Third Quarter 2025 Financial Results on November 5, 2025
businesswire.com
GERN
Geron Corporation Announces Executive Leadership Transitions and Appointments
globenewswire.com
GERN